Duration of antiplatelet or anticoagulant therapy after transcatheter aortic valve implantation in high risk patients; longer or shorter

Affiliations

¹ Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey. Electronic address: drcengizozturk@yahoo.com.tr.
² Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey.
³ Gulhane Military Medical Academy, School of Medicine, Department of Geriatric Medicine, Etlik, Ankara, Turkey.

Comment

Cengiz Ozturk et al. Int J Cardiol. 2016.

. 2016 May 1:210:14-5.

doi: 10.1016/j.ijcard.2016.02.111. Epub 2016 Feb 17.

¹ Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey. Electronic address: drcengizozturk@yahoo.com.tr.
² Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, Etlik, Ankara, Turkey.
³ Gulhane Military Medical Academy, School of Medicine, Department of Geriatric Medicine, Etlik, Ankara, Turkey.

No abstract available

Keywords: After transcatheter aortic valve implantation; Duration of antiplatelet therapy; High risk patients.

Comment on

Valve thrombosis 3years after transcatheter aortic valve implantation.
Toggweiler S, Schmidt K, Paul M, Cuculi F, Kobza R, Jamshidi P. Toggweiler S, et al. Int J Cardiol. 2016 Mar 15;207:122-4. doi: 10.1016/j.ijcard.2016.01.080. Epub 2016 Jan 9. Int J Cardiol. 2016. PMID: 26800132 Review. No abstract available.